Aktienanalyse zu CVS Health Corp (CVS)CVSCVS Health Corp

CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. The Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and, through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise. It operates in the Healthcare sector (RETAIL-DRUG STORES AND PROPRIETARY STORES industry).

CVS Health Corp is currently trading at $86.16, which is below the average analyst price target of $110, indicating potential upside. However, the RSI is at 39.75, suggesting that the stock is in a bearish trend and may not be the best time to buy. Additionally, the forward P/E ratio is 10.67, which is attractive, but the recent news about Medicare Advantage ratings declining could impact future earnings. The main risk is the expected decline in adjusted EPS by $0.41 in 2028 due to these rating changes, which could pressure profitability.